Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinzaparin in Pregnancy with Intrauterine Growth Restriction
NCT01390051Phase 4Completed
- Sponsor
- Aarhus University
- Start
- Jul 2011
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tinzaparin in intrauterine growth restriction (IUGR) (2 arms), sponsored by Aarhus University. Primary endpoint: Birth weight. Started Jul 2011; status: completed.
02
Drugs
tinzaparin
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on NCT01390051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01390051.